Physician profile
Stephen Manning
NPI 1902396724
$1,116.86
in general payments reported to CMS, 2019-2025
16 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.96 · 2022: $329 · 2023: $395 · 2024: $46.13 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728 · Education: $46.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.14 |
| Education | $46.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $255.16 | 2022-2023 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $234.26 | 2022-2025 | Lifevest |
| Abbott Laboratories | $101.99 | 2023 | Pressurewire |
| E.R. Squibb & Sons, L.L.C. | $93.94 | 2024-2025 | Eliquis, Camzyos |
| Pfizer INC. | $87.61 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $78.96 | 2023 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $50.89 | 2022 | |
| Medtronic, INC. | $36.13 | 2025 | Symplicity G3 |
| Bayer Healthcare Pharmaceuticals INC. | $36.07 | 2025 | |
| Novartis Pharmaceuticals Corporation | $34.90 | 2025 | |
| Chiesi USA, INC. | $20.93 | 2024 | Cleviprex, Kengreal |
| Bridgebio Pharma, INC. | $19.50 | 2025 | Attruby |
| United Therapeutics Corporation | $18.93 | 2023 | |
| Inspire Medical Systems, INC. | $18.90 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $14.73 | 2025 | Shingrix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Manning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.